Company Filing History:
1 out of 51 
1 out of 50 
1 out of 1 Years Active: 2021
Title: Bandar Alghanem: Innovator in Anticancer Research
Introduction
Bandar Alghanem is a notable inventor based in Riyadh, Saudi Arabia. He has made significant contributions to the field of cancer treatment through his innovative research and development of novel compounds. His work focuses on the synthesis of anticancer derivatives, showcasing his commitment to advancing medical science.
Latest Patents
Alghanem holds a patent for "Anticancer 1,3-dioxane-4,6-dione derivatives and method of combinatorial synthesis thereof." This patent details compounds, methods of synthesis, and methods of cancer treatment using arylidene-1,3-dioxane-4,6-diones. The methodology involves Meldrum's acid-based chemistry and a hybrid solid-liquid approach. Key steps in the process include the protection of ketone and aldehyde components, simultaneous immobilization on a solid phase, and the introduction of substituents and derivatives. The method also encompasses the detachment and restoration of active carbonyl reactivity, the reaction of a ketone library with malonate, and the subsequent reaction of products with an aldehyde library in the liquid phase, followed by separation using preparative HPLC.
Career Highlights
Throughout his career, Bandar Alghanem has worked with esteemed organizations such as the National Guard Health Affairs and King Saud Bin Abdulaziz University for Health Sciences. His experience in these institutions has allowed him to collaborate with leading professionals in the field and contribute to groundbreaking research.
Collaborations
Alghanem has collaborated with notable colleagues, including Imadul Islam and Rabih Omran Al-Kaysi. These partnerships have further enriched his research endeavors and expanded the impact of his work in the scientific community.
Conclusion
Bandar Alghanem's innovative contributions to anticancer research exemplify his dedication to improving healthcare outcomes. His patented methods and compounds represent a significant advancement in cancer treatment, highlighting the importance of continued research and collaboration in the field.